4.8 Article

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0813410106

关键词

CFTR; EN-RAGE; flow cytometry; S6 ribosomal protein; stromal derived factor-1

资金

  1. Cystic Fibrosis Foundation
  2. Stanford SPARK Program
  3. Stanford SCCTER Program
  4. Skippy and Sidney Frank Foundation

向作者/读者索取更多资源

Cystic fibrosis (CF) patients undergo progressive airway destruction caused in part by chronic neutrophilic inflammation. While opportunistic pathogens infecting CF airways can cause inflammation, we hypothesized that host-derived metabolic and stress signals would also play a role in this process. We show that neutrophils that have entered CF airways have increased phosphorylation of the eukaryotic initiation factor 4E and its partner the 4E-binding protein 1; 2 key effectors in the growth factor- and amino acid-regulated mammalian target of rapamycin (mTOR) pathway. Furthermore CF airway neutrophils display increased phosphorylation of the cAMP response element binding protein (CREB), a major transcriptional coactivator in stress signaling cascades. These active intracellular pathways are associated with increased surface expression of critical adaptor molecules, including the growth factor receptor CD114 and the receptor for advanced glycation end-products (RAGE), a CREB inducer and sensor for host-derived damage-associated molecular patterns (DAMPs). Most CF airway fluids lack any detectable soluble RAGE, an inhibitory decoy receptor for DAMPs. Concomitantly, CF airway fluids displayed high and consequently unopposed levels of S100A12; a potent mucosa- and neutrophil-derived DAMP. CF airway neutrophils also show increased surface levels of 2 critical CREB targets, the purine-recycling enzyme CD39 and the multifunctional, mTOR-inducing CXCR4 receptor. This coordinated set of events occurs in all patients, even in the context of minimal airway inflammation and well-preserved lung function. Taken together, our data demonstrate an early and sustained activation of host-responsive metabolic and stress pathways upon neutrophil entry into CF airways, suggesting potential targets for therapeutic modulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pediatrics

Manifestations of pulmonary aspergillosis in pediatrics

Archana Chacko, Richard B. Moss

CURRENT OPINION IN PEDIATRICS (2020)

Review Allergy

Biomarkers for the Diagnosis of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: A Systematic Review and Meta-Analysis

Brian C. M. Li, Sung Moon Huh, Miguel D. Prieto, Gina Hong, Carsten Schwarz, Richard B. Moss, Bradley S. Quon

Summary: Diagnosing ABPA in CF patients can be challenging, but recent studies have identified promising biomarkers that may aid in diagnosis. Further research is needed to understand their utility better.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Surgery

Remote intervention engagement and outcomes in the Clinical Trials in Organ Transplantation in Children consortium multisite trial

Sarah Duncan-Park, Claire Dunphy, Jacqueline Becker, Christine D'Urso, Rachel Annunziato, Joshua Blatter, Carol Conrad, Samuel B. Goldfarb, Don Hayes, Ernestina Melicoff, Marc Schecter, Gary Visner, Brian Armstrong, Hyunsook Chin, Karen Kesler, Nikki M. Williams, Jonah N. Odim, Stuart C. Sweet, Lara Danziger-Isakov, Eyal Shemesh

Summary: The study found that remote interventions in pediatric lung transplant recipients can effectively reduce medication level variability, improve blood level stability, and participants successfully completed long-term remote interventions.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Editorial Material Allergy

Diagnosing allergic bronchopulmonary aspergillosis/mycosis: Return to lost horizons

Richard B. Moss

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Respiratory System

Clinician variability in the diagnosis and treatment of aspergillus fumigatus-related conditions in cystic fibrosis: An international survey

Gina Hong, Sameer Desai, Richard B. Moss, Patience Eschenhagen, Bradley S. Quon, Carsten Schwarz

Summary: There are significant variations in the diagnosis and management of Aspergillus-related conditions in CF. Future studies are needed to better harmonize the approach to Af-related disease in CF.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Surgery

CTOTC-08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients

Stuart C. Sweet, Brian Armstrong, Joshua Blatter, Hyunsook Chin, Carol Conrad, Samuel Goldfarb, Don Hayes, Peter S. Heeger, Victoria Lyou, Ernestina Melicoff-Portillo, Thalachallour Mohanakumar, Jonah Odim, Ranjithkumar Ravichandran, Marc Schecter, Gregory A. Storch, Gary Visner, Nikki M. Williams, Lara Danziger-Isakov

Summary: The study showed that rituximab induction may prevent early DSA development in pediatric lung transplant recipients without adverse effects, but did not significantly differ from the placebo group in terms of the primary endpoint and incidence of adverse events.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Pediatrics

Auto-inflammation and auto-immunity pathways are associated with emergence of BOS in pediatric lung transplantation

Carol K. Conrad, Haley Hedlin, Hyunsook Chin, Don Hayes, Peter S. Heeger, Albert Faro, Samuel Goldfarb, Ernestina Melicoff-Portillo, Mohanakumar Thalachallour, Jonah Odim, Marc Schecter, Gregory A. Storch, Gary A. Visner, Nikki M. Williams, Karen Kesler, Lara Danziger-Isakov, Stuart C. Sweet

Summary: Cytokine analysis of bronchoalveolar lavage fluid samples from pediatric lung transplant recipients revealed that elevated levels of IL-23 and IL-31 were associated with an increased risk of bronchiolitis obliterans, while lower levels of epithelial growth factor and eotaxin were associated with bronchiolitis obliterans. Furthermore, soluble CD30, pro-inflammatory cytokine IL-23, and sTNFRI levels below cutoff levels were found to be associated with bronchiolitis obliterans-free survival.

PEDIATRIC TRANSPLANTATION (2022)

Article Microbiology

Macrophage Lysosomal Alkalinization Drives Invasive Aspergillosis in a Mouse Cystic Fibrosis Model of Airway Transplantation

Efthymia Iliana Matthaiou, Wayland Chiu, Carol Conrad, Joe Hsu

Summary: Cystic fibrosis lung transplant recipients are at a higher risk of life-threatening invasive aspergillosis. Alkalization of macrophages lacking the CFTR gene is associated with this increased risk, and the presence of iron in the post-transplant microenvironment exacerbates this alkalization. The alkalization impairs the ability of macrophages to clear Aspergillus fumigatus conidia. pH modulation after transplantation may be a therapeutic strategy to reduce the risk of invasive aspergillosis.

JOURNAL OF FUNGI (2022)

Article Respiratory System

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation

Gregory S. Sawicki, Michael W. Konstan, Edward F. McKone, Richard B. Moss, Barry Lubarsky, Ellison Suthoff, Stefanie J. Millar, David J. Pasta, Nicole Mayer-Hamblett, Christopher H. Goss, Wayne J. Morgan, Margaret E. Duncan, Yoojung Yang

Summary: This study examined the rate of lung function decline in cystic fibrosis patients with F/RF genotypes. The results showed that lung function declines over time in patients of all ages with F/RF genotypes. This finding emphasizes the importance of early intervention and clinical monitoring to preserve lung function in all cystic fibrosis patients.

PULMONARY THERAPY (2022)

Article Microbiology

Severe Fungal Asthma: A Role for Biologics and Inhaled Antifungals

Richard B. B. Moss

Summary: Allergic asthma has traditionally been treated with inhaled and systemic glucocorticosteroids. A continuum of allergic fungal airways disease associated with Aspergillus fumigatus colonization and/or atopic immune responses that encompasses fungal asthma, severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis is now recognized along a phenotypic severity spectrum of T2-high immune deviation lung disease. Oral triazoles have shown clinical, anti-inflammatory and microbiologic efficacy in this setting; in the future inhaled antifungals may improve the therapeutic index. Humanized monoclonal antibody biologic agents targeting T2-high disease also show efficacy and promise of improved control in difficult cases. Developments in these areas are highlighted in this overview.

JOURNAL OF FUNGI (2023)

Article Immunology

Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019 (COVID-19): A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Joseph E. Levitt, Haley Hedlin, Sophie Duong, Di Lu, Justin Lee, Bryan Bunning, Nadia Elkarra, Benjamin A. Pinsky, Eileen Heffernan, Eric Springman, Richard B. Moss, Hector F. Bonilla, Julie Parsonnet, Roham T. Zamanian, Jamison J. Langguth, Jenna Bollyky, Chaitan Khosla, Mark R. Nicolls, Manisha Desai, Angela J. Rogers

Summary: The study aimed to evaluate the effectiveness of Acebilustat in treating outpatients with COVID-19, and the results showed that the medication did not shorten symptom duration.

CLINICAL INFECTIOUS DISEASES (2023)

Article Pediatrics

The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort

Rebekah H. Nevel, Gail Deutsch, Daniel Craven, Robin P. Deterding, Martha A. Fishman, Jennifer Wambach, Alicia Casey, Katie R. Krone, Deborah G. Liptzin, Michael O'Connor, Geoffrey B. Kurland, Jane A. Taylor, William S. Gower, James Hagood, Carol B. Conrad, Jade K. Tam-Williams, Elizabeth Fiorino, Samuel C. Goldfarb, Sara M. Sadreameli, Lawrence Nogee, Gregory Montgomery, Aaron A. Hamvas, Theresa Laguna, Manvi Bansal, Cheryl Lew, Maria Santiago, Antonia Popova, Aliva De, Marilynn R. Chan, Michael B. Powers, Maureen Josephson, Devaney Camburn, Laura Voss, Yun R. Li, Lisa Young

Summary: Childhood interstitial and diffuse lung disease (chILD) encompasses a broad spectrum of rare disorders. The Children's Interstitial and Diffuse Lung Disease Research Network (chILDRN) established a prospective registry to advance knowledge regarding these disorders.

PEDIATRIC PULMONOLOGY (2023)

暂无数据